相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The polymorphisms in the VHL and HIF1A genes are associated with the prognosis but not the development of renal cell carcinoma
C. Qin et al.
ANNALS OF ONCOLOGY (2012)
A functional polymorphism C-1310G in the promoter region of Ku70/XRCC6 is associated with risk of renal cell carcinoma
Wei Wang et al.
MOLECULAR CARCINOGENESIS (2012)
Overexpression of the mammalian target of rapamycin (mTOR) and angioinvasion are poor prognostic factors in early stage NSCLC: A verification study
K. Gately et al.
LUNG CANCER (2012)
Genetic Polymorphisms Associated with a Prolonged Progression-Free Survival in Patients with Metastatic Renal Cell Cancer Treated with Sunitinib
Astrid A. M. van der Veldt et al.
CLINICAL CANCER RESEARCH (2011)
Mammalian target of rapamycin expression and laryngeal squamous cell carcinoma prognosis: novel preliminary evidence
Gino Marioni et al.
HISTOPATHOLOGY (2011)
Pazopanib Efficacy in Renal Cell Carcinoma: Evidence for Predictive Genetic Markers in Angiogenesis-Related and Exposure-Related Genes
Chun-Fang Xu et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Characterization and targeting of phosphatidylinositol-3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in renal cell cancer
Aymen A. Elfiky et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3
Mark P. Purdue et al.
NATURE GENETICS (2011)
Phase II Trial of Bevacizumab and Everolimus in Patients With Advanced Renal Cell Carcinoma
John D. Hainsworth et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
VHL and HIF signalling in renal cell carcinogenesis
Marcella M. Baldewijns et al.
JOURNAL OF PATHOLOGY (2010)
VEGF Polymorphisms are Associated With an Increasing Risk of Developing Renal Cell Carcinoma
Franck Bruyere et al.
JOURNAL OF UROLOGY (2010)
Epidemiology and risk factors for kidney cancer
Wong-Ho Chow et al.
NATURE REVIEWS UROLOGY (2010)
Genetic Variations in the PI3K/PTEN/AKT/mTOR Pathway Are Associated With Clinical Outcomes in Esophageal Cancer Patients Treated With Chemoradiotherapy
Michelle A. T. Hildebrandt et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
A novel functional polymorphism C1797G in the MDM2 promoter is associated with risk of bladder cancer in a chinese population
Meilin Wang et al.
CLINICAL CANCER RESEARCH (2008)
Activated mammalian target of rapamycin is an adverse prognostic factor in patients with biliary tract adenocarcinoma
Beata Herberger et al.
CLINICAL CANCER RESEARCH (2007)
The phosphoinositide 3-kinase pathway in human cancer: Genetic alterations and therapeutic implications
Alexandre Arcaro et al.
CURRENT GENOMICS (2007)
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma
Gary Hudes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The phosphoinositide 3-kinase/Akt pathway: A new target in human renal cell carcinoma therapy
Carole Sourbier et al.
CANCER RESEARCH (2006)
Renal-cell carcinoma
HT Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Perturbations of the AKT signaling pathway in human cancer
DA Altomare et al.
ONCOGENE (2005)
Polymorphisms in the hypoxia inducible factor-1α gene (HIF1A) are associated with the renal cell carcinoma phenotype
M Ollerenshaw et al.
CANCER GENETICS AND CYTOGENETICS (2004)
Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers
XY Zhou et al.
CLINICAL CANCER RESEARCH (2004)
Essential role of AKT-1/protein kinase Bα in PTEN-controlled tumorigenesis
B Stiles et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Cell signaling by receptor tyrosine kinases
J Schlessinger
CELL (2000)
分享论文
